P
Peter M. Pollak
Researcher at Mayo Clinic
Publications - 53
Citations - 1260
Peter M. Pollak is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 9, co-authored 40 publications receiving 423 citations. Previous affiliations of Peter M. Pollak include Boston Scientific Corporation.
Papers
More filters
Journal ArticleDOI
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
Dawn Kleindorfer,Amytis Towfighi,Seemant Chaturvedi,Kevin M. Cockroft,Jose Gutierrez,Debbie Lombardi-Hill,Hooman Kamel,Walter N. Kernan,Steven J. Kittner,Enrique C. Leira,Olive Lennon,James F. Meschia,Thanh N. Nguyen,Peter M. Pollak,Pasquale Santangeli,Anjail Sharrief,Sidney C. Smith,Tanya N. Turan,Linda S. Williams +18 more
Journal ArticleDOI
Early Outcomes of Percutaneous Transvenous Transseptal Transcatheter Valve Implantation in Failed Bioprosthetic Mitral Valves, Ring Annuloplasty, and Severe Mitral Annular Calcification
Mackram F. Eleid,Brian Whisenant,Allison K. Cabalka,Mathew R. Williams,Mohammed Nejjari,David Attias,Neil Fam,Nicholas Amoroso,Thomas A. Foley,Peter M. Pollak,Oluseun Alli,Sorin V. Pislaru,Sameh M. Said,Joseph A. Dearani,Charanjit S. Rihal +14 more
TL;DR: Transfemoral percutaneous transvenous mitral valve implantation in high-risk patients with degenerated bioprosthesis is safe, effective, and associated with rapid improvement in hemodynamics, short length of stays, and improved functional status.
Journal ArticleDOI
Techniques and Outcomes of Percutaneous Aortic Paravalvular Leak Closure.
Mohamad Alkhouli,Mohammad Sarraf,Elad Maor,Saurabh Sanon,Allison K. Cabalka,Mackram F. Eleid,Donald J. Hagler,Peter M. Pollak,Guy S. Reeder,Charanjit S. Rihal +9 more
TL;DR: Percutaneous reduction of aortic PVL is associated with durable symptom relief and lower rates of repeat cardiac surgery, and the magnitude of benefit is greatest with PVL reduction to a grade of mild or less.
Journal ArticleDOI
Transcatheter closure of postmyocardial infarction, iatrogenic, and postoperative ventricular septal defects: The Mayo Clinic experience.
Alexander C. Egbe,Joseph T. Poterucha,Charanjit S. Rihal,Nathaniel W. Taggart,Frank Cetta,Allison K. Cabalka,Peter M. Pollak,Guy S. Reeder,Donald J. Hagler +8 more
TL;DR: To determine event‐free survival after transcatheter closure of ventricular septal defect (VSD) and to identify predictors of adverse events (AE) in post myocardial infarction VSD (post‐MI VSD) subgroup.
Journal ArticleDOI
von Willebrand Factor Abnormalities and Heyde Syndrome in Dysfunctional Heart Valve Prostheses.
Joseph L. Blackshear,Chad McRee,Robert E. Safford,Peter M. Pollak,Mark E. Stark,Colleen S. Thomas,Candido E. Rivera,Ewa M. Wysokinska,Dong Chen +8 more
TL;DR: Acquired abnormalities of VWF multimers are associated with aortic and mitral prosthesis dysfunction, with occasional gastrointestinal bleeding and gastrointestinal angiodysplasia.